Physician Wealth Advisors’s BioNTech BNTX Stock Holding History

Physician Wealth Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.93K	Hold	53	–	–	﹤0.01%	1102
2026 Q1	$4.71K	Buy	+53	New	+$5.45K	﹤0.01%	1027
2025 Q3	–	Sell	-24	Closed	-$2.56K	–	1921
2025 Q2	$2.56K	Hold	24	–	–	﹤0.01%	965
2025 Q1	$2.19K	Hold	24	–	–	﹤0.01%	849
2024 Q4	$2.73K	Buy	+24	New	+$2.74K	﹤0.01%	816

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Physician Wealth Advisors's BNTX Position: Q2 2026 in Review

Physician Wealth Advisors held its BioNTech (BNTX) position steady in Q2 2026 at 53 shares worth $4.93K. The position accounts for ﹤0.01% of the portfolio, ranked #1102.

Physician Wealth Advisors first reported a position in BNTX in Q4 2024 and has held it in 5 quarters since. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Physician Wealth Advisors held 53 shares of BioNTech worth $4.93K as of Q2 2026.
Physician Wealth Advisors left its BioNTech share count unchanged in Q2 2026.
BioNTech made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1102 holding.
Physician Wealth Advisors first reported a position in BioNTech in Q4 2024 and has held it in 5 quarters since.
283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.